<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T11:38:18Z</responseDate>
  <request identifier="oai:figshare.com:article/33770587" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33770587</identifier>
        <datestamp>2026-09-15T04:24:18Z</datestamp>
        <setSpec>category_658</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_Biochemical and renal-metabolic profiles distinguishing primary aldosteronism from essential hypertension: a systematic review and meta-analysis with implications for endocrine hypertension screening.docx</dc:title>
          <dc:creator>Xuan Zhao (356028)</dc:creator>
          <dc:creator>Caiyan Zhang (9433364)</dc:creator>
          <dc:creator>Chunxiu Yi (24911824)</dc:creator>
          <dc:creator>Xinyi Liu (186154)</dc:creator>
          <dc:creator>Shujun Ding (414103)</dc:creator>
          <dc:creator>Wen Zhang (7555)</dc:creator>
          <dc:creator>Yajing Zhao (1571059)</dc:creator>
          <dc:subject>Cell Metabolism</dc:subject>
          <dc:subject>primary aldosteronism</dc:subject>
          <dc:subject>essential hypertension</dc:subject>
          <dc:subject>serum potassium</dc:subject>
          <dc:subject>serum sodium</dc:subject>
          <dc:subject>albuminuria</dc:subject>
          <dc:subject>meta-analysis</dc:subject>
          <dc:description>Introduction&lt;p&gt;To characterize electrolyte and renal-metabolic profiles in primary aldosteronism (PA) compared with essential hypertension (EH), and to examine differences between unilateral/lateralizing and bilateral PA.&lt;/p&gt;Methods&lt;p&gt;PubMed, Embase, the Cochrane Library, and Web of Science were searched from inception through 13 July 2026. Random-effects meta-analyses pooled standardized mean differences (SMD; Hedges' g), supplemented by clinical-unit mean-difference analyses, subgroup analyses, sensitivity analyses, and study-level meta-regression.&lt;/p&gt;Results&lt;p&gt;A total of 74 observational studies involving 26,143 participants were included. Compared with hypertensive controls, PA was associated with lower serum potassium (SMD = −1.15, 95% CI −1.27 to −1.02), higher serum sodium (SMD = 0.51, 95% CI 0.38 to 0.63), and lower uric acid (SMD = −0.23, 95% CI −0.35 to −0.12), whereas creatinine, estimated glomerular filtration rate (eGFR), and blood urea nitrogen (BUN) did not differ significantly. Corresponding PA-minus-control mean differences were −0.49 mmol/L for potassium, +1.20 mmol/L for sodium, and −20.7 μmol/L for uric acid. Potassium was lower in unilateral/lateralizing than in bilateral PA (SMD = −0.85). The potassium difference versus controls was greater in studies with high plasma aldosterone concentration (PAC) than in those with low PAC (SMD −1.44 vs. −1.03; p for subgroup difference = 0.010), although continuous PAC meta-regression was not significant. UACR/ACR and urinary albumin excretion were higher in PA (SMD = 0.49 and 0.73).&lt;/p&gt;Discussion&lt;p&gt;PA shows a persistent electrolyte phenotype and higher albuminuria despite similar cross-sectional filtration markers. These findings support renal assessment with UACR alongside routine filtration measures and reinforce that PA screening should not depend on overt hypokalemia alone.&lt;/p&gt;Systematic Review Registration&lt;p&gt;https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261286832.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T04:24:18Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fendo.2026.1916237.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_Biochemical_and_renal-metabolic_profiles_distinguishing_primary_aldosteronism_from_essential_hypertension_a_systematic_review_and_meta-analysis_with_implications_for_endocrine_hypertension_screening_docx/33770587</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
